How the Crimean-Congo hemorrhagic fever virus enters our cells

  • 📰 ScienceDaily
  • ⏱ Reading Time:
  • 35 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 17%
  • Publisher: 53%

Health Health Headlines News

Health Health Latest News,Health Health Headlines

Researchers have identified how the tick-borne Crimean-Congo haemorrhagic fever virus enters our cells. The results are an important step in the development of drugs against the deadly disease.

Researchers at Karolinska Institutet, in collaboration with JLP Health and others, have identified how the tick-borne Crimean-Congo haemorrhagic fever virus enters our cells. The results are published inand are an important step in the development of drugs against the deadly disease.

To identify the protein, the researchers used human mini-organs grown in test tubes and an advanced stem cell library from JLP Health. The same platform has previously been used to identify how the Ebola virus enters cells. This knowledge is essential if the disease were to become more common and spread to new areas. Normally it takes many years to develop a drug, but the COVID-19 pandemic and the development of the SARS-CoV-2 vaccine showed that it can be done much faster if everyone decides it is a priority."This is an important step in our preparedness for the disease," says Ali Mirazimi."Crimean-Congo haemorrhagic fever is a disease we would rather not have.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 452. in HEALTH

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Researchers Say COVID-19 Virus Can Stay In the Body Up To Two YearsI cover health in Southern California.
Source: LAist - 🏆 606. / 51 Read more »

Researchers turn back the clock on cancer cells to offer new treatment paradigmScientists reversed an aggressive cancer, reverting malignant cells towards a more normal state. Rhabdoid tumors are an aggressive cancer which is missing a key tumor suppressor protein. Scientists discovered that removing a second protein from cancer cells already experiencing tumor suppressor loss can reverse cancer cell identity.
Source: ScienceDaily - 🏆 452. / 53 Read more »